Greater consumption of red meat has been linked to a higher risk of mortality and chronic diseases, including diabetes. We aim to examine the associations between total, processed, and unprocessed red meat intake and diabetes, and to evaluate the substitution effects of other protein sources for red meat on diabetes. This population-based cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) 2003-2016. Diabetes was defined as being diagnosed by a physician or other health professional, having a fasting plasma glucose of 126 mg/dL or higher, an HbA1c level of 6.5% or higher, or the use of antidiabetic drugs. Multivariable logistic regression models were conducted. The study included 34,737 adult participants (mean (SD) age of 45.8 (17.5) years) from NHANES 2003-2016. After adjusting for major confounders, compared to the first quintile, higher intakes of total, processed, and unprocessed red meat were positively associated with higher odds of diabetes, with adjusted odds ratios of 1.49 (95% CI, 1.22-1.81), 1.47 (95% CI, 1.17-1.84), and 1.24 (95% CI, 1.06-1.44), respectively (P- trend for all < 0. 001). In this nationally representative sample of U.S. adults, participants in the highest quintiles of total, processed, and unprocessed red meat intake had higher odds of diabetes than those in the lowest quintile. Substituting 1 serving/day of dietary protein from foods of plant origin (including nuts, seeds, legumes, and soy) for total, processed, or unprocessed red meat was associated with 9% to 14% lower odds of diabetes.

Eating duration and shift work can both influence metabolic regulation, but their joint associations with diabetes are unknown. We aimed to examine the independent and joint associations of eating duration and shift work with diabetes in a cross-sectional study using a nationally representative sample of US workers. We included 14852 eligible participants from the National Health and Nutrition Examination Survey, 2005–2010 and 2017–2020. Eating duration was calculated based on first and last eating occasions from 24-h dietary recalls. Long eating duration (LED: ≥ 13 h) v. short eating duration (SED: < 13 h) was defined based on the median. Workers were classified as engaging in shift work (SW, n 5140) v. non-shift work (NSW, n 8945) based on self-report. Logistic regressions were used to examine the associations of LED and SW with diabetes, independently and jointly with stratification by age. LED was associated with higher odds of diabetes among workers aged < 45 years (OR, 1·51; 95 % CI, 1·05–2·19) but not among workers aged ≥ 45 years (OR, 0·98; 95 % CI, 0·79–1·20). SW was associated with higher odds of diabetes among both younger (OR, 1·28; 95 % CI, 0·88–1·85) and older workers (OR, 1·28; 95 % CI, 1·04–1·58). There was suggestive evidence that workers with both LED and SW had higher odds of diabetes compared with those with SED and NSW, but the association was stronger among younger (OR, 1·40; 95 % CI, 0·85–2·28) than older workers (OR, 1·28; 95 % CI, 0·99–1·66). LED and SW were independently associated with increased odds of diabetes with suggestive evidence on their joint associations, but associations varied by workers’ age.

White potatoes are a major contributor to energy and nutrient intake in the USA, which supports investigating their relationship with cardiometabolic health. This cross-sectional analysis assessed relationships of total white potato intake and dietary patterns containing white potatoes prepared by various methods with markers of cardiometabolic health in adults categorised by diabetes status. The dietary intake assessment component of the National Health and Nutrition Examination Survey (2001–2018), What We Eat in America (WWEIA), was linked with the Food and Nutrient Database for Dietary Studies and Food Patterns Equivalents Database to rank the consumption of white potato-containing foods. Dietary patterns were determined by percent calories from white potatoes and main food groups in WWEIA using cluster analysis. Regression analysis assessed trends in individuals with (n 5467) and without (n 38 159) diagnosed diabetes. P < 0·01 was significant. The most consumed white potato-containing foods were French fries, potato chips and home fries. In adults without diagnosed diabetes, total white potato intake was positively associated with glucose, insulin, Homeostatic Model Assessment for Insulin Resistance and waist circumference. Glycated Hb was lower in those who primarily consumed dietary patterns with baked/boiled potatoes, and waist circumference was higher in those who primarily consumed dietary patterns with chips, fried potatoes or mashed potatoes compared with adults with no white potato intake. In adults without diagnosed diabetes, total white potato intake was associated with greater cardiometabolic risk, which may be due, in part, to frying as the predominate preparation method of white potatoes in the USA.

Alpha-ketoglutarate (AKG) is a well-known intermediate of the tricarboxylic acid cycle and plays an important role in the catabolism of branched-chain amino acids (BCAAs: leucine, isoleucine, and valine). While previous study suggested that AKG enhances glucose metabolism, its effect on the adaptation of muscles and adipocytes has not been well studied in diabetic condition. This study aimed to determine whether AKG improves glucose metabolism in the skeletal muscles and adipose tissues in diabetic mice. Male institute of cancer research mice were divided into control, diabetic, and diabetic + AKG groups. Diabetes (DM) was induced by a high fat diet consumption and streptozotocin (STZ) injection. Mice in the DM + AKG group were administered 1% AKG in drinking water for 6 weeks. The non-fasting plasma glucose level was significantly higher in the diabetic group than that in the control and DM + AKG groups (P < 0.05). No significant difference was observed in glucose transporter 4 (GLUT4) protein levels in the muscles between the DM and DM + AKG groups. AKG supplementation attenuated the decrease in peroxisome proliferator-activated receptor γ coactivator 1 alpha and GLUT4 protein levels in inguinal and epididymal adipose tissues in diabetic condition. In conclusion, the study findings suggested that AKG supplementation increased protein levels related to mitochondrial biogenesis and glucose transporters in adipocyte tissue accompanied with improved whole-body glucose metabolism in STZ and high-fat diet-induced diabetic mice.

Evidence regarding the association between dietary choline intake and mortality in individuals with diabetes remains limited. This study aimed to evaluate the relationship between dietary choline intake and all-cause, CVD and cancer-related mortality among adults with diabetes. A total of 4712 participants with diabetes were included from the National Health and Nutrition Examination Survey 2007–2018 cycles. Dietary choline intake was estimated using two 24-h dietary recalls, and mortality outcomes were ascertained via linkage to National Death Index records through 31 December 2019. Cox proportional hazards models and Kaplan-Meier analyses were employed to assess the associations between choline intake and mortality. Restricted cubic spline models were used to examine potential non-linear relationships, and threshold analyses were conducted to identify inflection points. Over a median follow-up of 6·42 years, 805 deaths were documented, including 267 from CVD and 126 from cancer. A U-shaped association was observed between dietary choline intake and all-cause mortality (Pfor non-linearity < 0·0001). Compared with the lowest quartile, multivariable-adjusted hazard ratios for all-cause mortality were 0·64 (95 % CI 0·47, 0·88) for the second quartile, 0·59 (0·43, 0·82) for the third and 0·69 (0·43, 1·09) for the highest quartile. No significant associations were found between choline intake and either CVD or cancer mortality. These findings indicate a U-shaped relationship between dietary choline intake and all-cause mortality in individuals with diabetes, with intakes between 286·77 and 538·86 mg/d associated with the lowest risk – providing potential implications for dietary guidance in diabetes management.

Tamil immigrants in Canada face high rates of Type II Diabetes Mellitus (T2DM) and significant barriers in accessing T2DM-related services. These barriers are often amplified for older adults, whose age-related needs intersect with cultural, linguistic, and socioeconomic factors. This study explored the lived experiences of Tamil older adults accessing T2DM-related health care services in the Greater Toronto Area. A qualitative interpretive description approach was used, involving in-depth semi-structured interviews with nine Tamil older adults. Participants were recruited through purposive and snowball sampling. Thematic analysis was applied, with findings organized using Levesque et al.’s framework (2013). Five key themes were identified: (1) timely and informed diabetes management, (2) reliance on trusted health service providers, (3) reliance on others for transportation, (4) financial factors, and (5) navigating health care through cultural and communication factors. Identified themes can inform potential solutions to improve access including centralized resource hubs, culturally tailored education programs, affordable transportation options, and an integrated health care approach.

Type 2 diabetes (T2D) incidence has been steadily increasing over the past few decades. Several studies have evaluated the effect of plant-based, vegetarian or vegan diets on the risk of T2D, although their potential benefits need to be confirmed and characterised. We performed a literature search up to 10 July 2025, using the terms/keywords related to plant-based index (PDI), vegetarian/vegan diets and T2D. We included observational non-experimental studies evaluating adherence to such diets in adult subjects assessing T2D risk. We specifically considered overall PDI and related healthy PDI (hPDI) and unhealthy PDI (uPDI), assessing intake of different food groups. We included 36 studies published between 1999 and 2025. We found an inverse association between adherence to vegetarian/plant-based dietary patterns and T2D risk. This association was stronger, though statistically imprecise, for the vegan diet (RR = 0·65, 95 % CI 0·42, 1·00) and for lacto-ovo-vegetarian diet (RR = 0·68, 0·57, 0·82). For studies using plant-based indices, the RR were 0·82 (0·69, 0·82), 0·76 (0·69, 0·82) and 1·13 (0·98, 1·30) for overall PDI, hPDI and uPDI, respectively. In the dose–response meta-analysis, overall PDI and hPDI showed an inverse and almost linear association with T2D risk. Conversely, adherence to uPDI directly correlated with T2D risk. Overall, adherence to vegan/vegetarian diets may reduce T2D risk, while an unhealthy plant-based diet appears to linearly increase disease risk, indicating caution in the consumption of such unhealthy foods even if of plant origin. The beneficial association between vegetarian and healthy plant-based diets may have major public health implications.

Impaired glycaemic control is a major risk factor for developing type 2 diabetes (T2D), a worldwide health epidemic intrinsically linked to diet and obesity. Whey proteins (WP) are increasingly popular supplements that are a rich source of branched-chain amino acids (BCAA), essential for muscle protein synthesis and metabolic regulation. In humans, fasting plasma concentrations of BCAA are maintained around 350 µM but become chronically elevated by 10–25% in persons with T2D. Little is known about whether BCAA from WP impacts circulating BCAA concentrations and contributes to this phenomenon. This narrative review used a systematic search approach with relevant keywords to identify evidence from randomised controlled trials in normoglycaemic humans and those with insulin resistance or T2D, on the effects of WP intake on plasma BCAA and glycaemic control. This review is, to the authors’ knowledge, the first to specifically examine the effects of WP intake on plasma BCAA concentrations in relation to glycaemic control. Whilst the majority of acute studies identified (n = 6) reported that WP consumption between 10 and 50 g significantly elevates postprandial BCAA and insulin responses (as evidenced by peak concentration and/or area under the curve), evidence from chronic studies (n = 3) report inconsistent findings on the impact of 9–51 g of WP/d on fasting BCAA and glycaemic control (for example, fasting glucose and insulin, insulin clearance). Findings from this literature review highlight the need for further studies that investigate the relationship between WP consumption with BCAA and glycaemic control, and to determine underlying mechanisms of action.

Parkinson’s disease (PD) is a severe neurodegenerative disorder characterized by prominent motor and non-motor (e.g., cognitive) abnormalities. Notwithstanding Food and Drug Administration (FDA)-approved treatments (e.g., L-dopa), most persons with PD do not adequately benefit from the FDA-approved treatments and treatment emergent adverse events are often reasons for discontinuation. To date, no current therapy for PD is disease modifying or curative. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are central nervous system (CNS) penetrant and have shown to be neuroprotective against oxidative stress, neuroinflammation, and insulin resistance, as well as promoting neuroplasticity. Preclinical evidence suggests that GLP-1RAs also attenuate the accumulation of α-synuclein. The cellular and molecular effects of GLP-1RAs provide a basis to hypothesize putative therapeutic benefit in individuals with PD. Extant preclinical and clinical trial evidence in PD provide preliminary evidence of clinically meaningful benefit in the cardinal features of PD. Herein, we synthesize extant preclinical and early-phase clinical evidence, suggesting that GLP-1RAs may be beneficial as a treatment and/or illness progression modification therapeutic in PD.